- KAPI Position on Parallel Importation Framework
- Pharmacy-mediated interchangeability for Similar Biotherapeutic Products (SBPs)
- IFPMA Position on Convergence of Good Manufacturing Practice (GMP) standards and Related Inspections
- IFPMA – Good Manufacturing Practice Inspections and the Provision of Batch Records1 in Sub-Saharan Africa
- IFPMA – Pharmacovigilance of biotherapeutic medicines
- IFPMA Position Paper on the Handling of Post-approval Changes to Marketing Authorizations
- Considerations for physicians on switching decisions regarding biosimilars
